The MS-STAT trial: a randomised placebo-controlled phase II trial of high dose simvastatin in secondary progressive multiple sclerosis (SPMS)

被引：0
|
作者：
Chataway, J. [1 ,2 ,3 ]
Alsanousi, A. [3 ]
Chan, D. [4 ]
Macmanus, D. [2 ]
Hunter, K. [2 ]
Foster, J. [2 ]
Bangham, C. [3 ]
Wilkie, D. [3 ]
Nicholas, J. [5 ]
Calder, V. [6 ]
Greenwood, J. [6 ]
Frost, C. [5 ]
Nicholas, R. [3 ]
机构：
[1] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[2] UCL, UCL Inst Neurol, London, England
[3] Imperial Coll Healthcare NHS Trust, London, England
[4] Brighton & Sussex Med Sch, Brighton, E Sussex, England
[5] London Sch Hyg & Trop Med, London, England
[6] UCL, UCL Inst Ophthalmol, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [41] A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
    Vollmer, T. L.
    Sorensen, P. S.
    Selmaj, K.
    Zipp, F.
    Havrdova, E.
    Cohen, J. A.
    Sasson, N.
    Gilgun-Sherki, Y.
    Arnold, D. L.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 (04) : 773 - 783
  • [42] A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
    T. L. Vollmer
    P. S. Sorensen
    K. Selmaj
    F. Zipp
    E. Havrdova
    J. A. Cohen
    N. Sasson
    Y. Gilgun-Sherki
    D. L. Arnold
    [J]. Journal of Neurology, 2014, 261 : 773 - 783
  • [43] MS-SMART trial design and recruitment status: a multi-arm phase IIB randomised double blind placebo-controlled clinical trial comparing the efficacy of three repositioned neuroprotective drugs in secondary progressive multiple sclerosis
    Connick, P.
    Miller, D.
    Pavitt, S.
    Giovannoni, G.
    Wheeler-Kingshott, C.
    Weir, C.
    Stallard, N.
    Hawkins, C.
    Sharrack, B.
    Cranswick, G.
    Chandran, S.
    Chataway, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 630 - 631
  • [44] SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial
    Jameson, Michael B.
    Gormly, Kirsten
    Espinoza, David
    Hague, Wendy
    Asghari, Gholamreza
    Jeffery, Grahame Mark
    Price, Timothy Jay
    Karapetis, Christos Stelios
    Arendse, Michael
    Armstrong, James
    Childs, John
    Frizelle, Frank A.
    Ngan, Sam
    Stevenson, Andrew
    Oostendorp, Martinus
    Ackland, Stephen P.
    [J]. BMC CANCER, 2019, 19 (01)
  • [45] SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial
    Michael B. Jameson
    Kirsten Gormly
    David Espinoza
    Wendy Hague
    Gholamreza Asghari
    Grahame Mark Jeffery
    Timothy Jay Price
    Christos Stelios Karapetis
    Michael Arendse
    James Armstrong
    John Childs
    Frank A. Frizelle
    Sam Ngan
    Andrew Stevenson
    Martinus Oostendorp
    Stephen P. Ackland
    [J]. BMC Cancer, 19
  • [46] Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
    Kapoor, Raja
    Ho, Pei-Ran
    Campbell, Nolan
    Chang, Ih
    Deykin, Aaron
    Forrestal, Fiona
    Lucas, Nisha
    Yu, Bei
    Arnold, Douglas L.
    Freedman, Mark
    Goldman, Myia D.
    Hartung, Hans-Peter
    Kubala Havrdova, Eva
    Jeffery, Douglas
    Miller, Aaron
    Sellebjerg, Finn
    Cadavid, Diego
    Mikol, Dan
    Steiner, Deborah
    [J]. LANCET NEUROLOGY, 2018, 17 (05): : 405 - 415
  • [47] Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine
    T. Hayton
    J. Furby
    K. J. Smith
    D. R. Altmann
    R. Brenner
    J. Chataway
    K. Hunter
    D. J. Tozer
    D. H. Miller
    R. Kapoor
    [J]. Journal of Neurology, 2012, 259 : 505 - 514
  • [48] Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine
    Hayton, T.
    Furby, J.
    Smith, K. J.
    Altmann, D. R.
    Brenner, R.
    Chataway, J.
    Hunter, K.
    Tozer, D. J.
    Miller, D. H.
    Kapoor, R.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (03) : 505 - 514
  • [49] Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
    Hoeglinger, Guenter U.
    Litvan, Irene
    Mendonca, Nuno
    Wang, Deli
    Zheng, Hui
    Rendenbach-Mueller, Beatrice
    Lon, Hoi-Kei
    Jin, Ziyi
    Fisseha, Nahome
    Budur, Kumar
    Gold, Michael
    Ryman, Davis
    Florian, Hana
    [J]. LANCET NEUROLOGY, 2021, 20 (03): : 182 - 192
  • [50] Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial
    Thompson, Richard J.
    Arnell, Henrik
    Artan, Reha
    Baumann, Ulrich
    Calvo, Pier Luigi
    Czubkowski, Piotr
    Dalgic, Buket
    D'Antiga, Lorenzo
    Durmaz, Ozlem
    Fischler, Bjorn
    Gonzales, Emmanuel
    Grammatikopoulos, Tassos
    Gupte, Girish
    Hardikar, Winita
    Houwen, Roderick H. J.
    Kamath, Binita M.
    Karpen, Saul J.
    Kjems, Lise
    Lacaille, Florence
    Lachaux, Alain
    Lainka, Elke
    Mack, Cara L.
    Mattsson, Jan P.
    McKiernan, Patrick
    Ozen, Hasan
    Rajwal, Sanjay R.
    Roquelaure, Bertrand
    Shagrani, Mohammad
    Shteyer, Eyal
    Soufi, Nisreen
    Sturm, Ekkehard
    Tessier, Mary Elizabeth
    Verkade, Henkjan J.
    Horn, Patrick
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (09): : 830 - 842
12345